These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 27664330

  • 1. Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation.
    Wang L, Skotland T, Berge V, Sandvig K, Llorente A.
    Eur J Pharm Sci; 2017 Feb 15; 98():80-85. PubMed ID: 27664330
    [Abstract] [Full Text] [Related]

  • 2. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers.
    Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A.
    Eur J Cancer; 2017 Jan 15; 70():122-132. PubMed ID: 27914242
    [Abstract] [Full Text] [Related]

  • 3. Identification of prostate cancer biomarkers in urinary exosomes.
    Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A.
    Oncotarget; 2015 Oct 06; 6(30):30357-76. PubMed ID: 26196085
    [Abstract] [Full Text] [Related]

  • 4. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH, Ji J, Wang BC, Chen H, Yang ZH, Wang K, Luo CL, Zhang WW, Wang FB, Zhang XL.
    Cell Physiol Biochem; 2018 Oct 06; 46(2):532-545. PubMed ID: 29614511
    [Abstract] [Full Text] [Related]

  • 5. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A.
    Prostate; 2016 Jan 06; 76(1):68-79. PubMed ID: 26417675
    [Abstract] [Full Text] [Related]

  • 6. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS, von Hardenberg J, Gross JC, Erben P, Schnölzer M, Hausser I, Bugert P, Michel MS, Boutros M.
    Mol Cell Proteomics; 2017 Jun 06; 16(6):998-1008. PubMed ID: 28396511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteome.
    Erozenci LA, Böttger F, Bijnsdorp IV, Jimenez CR.
    FEBS Lett; 2019 Jul 06; 593(13):1580-1597. PubMed ID: 31198995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Niu L, Song X, Wang N, Xue L, Song X, Xie L.
    Cancer Sci; 2019 Jan 06; 110(1):433-442. PubMed ID: 30407700
    [Abstract] [Full Text] [Related]

  • 11. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, Bangma CH, Pettersson KS, Jenster G.
    Int J Cancer; 2015 Dec 15; 137(12):2869-78. PubMed ID: 26139298
    [Abstract] [Full Text] [Related]

  • 12. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M, Castells M, Bassas L, Vigués F, Larriba S.
    Sci Rep; 2019 Sep 24; 9(1):13772. PubMed ID: 31551516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 24; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory-Based Techniques: Protocol for a Case-Control Study.
    Li G, Tholance Y, Mallouk N, Waeckel L, Flandrin P, Bali B, Badet L, Cornillon P.
    JMIR Res Protoc; 2024 Sep 11; 13():e63551. PubMed ID: 39024018
    [Abstract] [Full Text] [Related]

  • 20. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
    Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullén A, Yachnin J, Nilsson S, Panaretakis T.
    Oncotarget; 2015 Aug 28; 6(25):21740-54. PubMed ID: 25844599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.